University of Alabama Wins $16 Million Grant to Develop Possible HIV Vaccine
August 12, 2003
The National Institute of Allergy and Infectious Diseases has awarded a $16 million grant to the University of Alabama-Birmingham to fund HIV vaccine development efforts. In a news release yesterday, UAB announced it has been chosen to lead the 4.5-year study, which will also be conducted at Harvard and Emory universities and at Novavax Inc. The team will develop and test a vaccine in animals, then conduct a small-scale study of the vaccine in humans. UAB professor of microbiology and medicine Dr. Jiri Mestecky will lead the study.
Merck Senior Vice President of Vaccine Research Leaving to Join International AIDS Vaccine Initiative
This article was provided by U.S. Centers for Disease Control and Prevention. It is a part of the publication CDC HIV/Hepatitis/STD/TB Prevention News Update. Visit the CDC's website to find out more about their activities, publications and services.